Structural insights into understudied human cytochrome P450 enzymes

Drug Discov Today. 2021 Oct;26(10):2456-2464. doi: 10.1016/j.drudis.2021.06.006. Epub 2021 Jun 20.

Abstract

Human cytochrome P450 (CYP) enzymes are widely known for their pivotal role in the metabolism of drugs and other xenobiotics as well as of endogenous chemicals. In addition, CYPs are involved in numerous pathophysiological pathways and, hence, are therapeutically relevant. Remarkably, a portion of promising CYP targets is still understudied and, as a consequence, untargeted, despite their huge therapeutic potential. An increasing number of X-ray and cryo-electron microscopy (EM) structures for CYPs have recently provided new insights into the structural basis of CYP function and potential ligand binding. This structural knowledge of CYP functionality is essential for both understanding metabolism and exploiting understudied CYPs as drug targets. In this review, we summarize and highlight structural knowledge about this enzyme class, with a focus on understudied CYPs and resulting opportunities for structure-based drug design. Teaser: This review summarizes recent structural insights into understudied cytochrome P450 enzymes. We highlight the impact of molecular modeling for mechanistically explaining pathophysiological effects establishing understudied CYPs as promising drug targets.

Keywords: CYP; Cancer; Cytochrome P450; Genetic disease; Homology modeling; Metabolism; Molecular modeling; Mutation; Protein structure.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cytochrome P-450 Enzyme System / chemistry*
  • Cytochrome P-450 Enzyme System / metabolism
  • Humans
  • Ligands
  • Models, Molecular*
  • Pharmaceutical Preparations / metabolism*
  • Xenobiotics / metabolism

Substances

  • Ligands
  • Pharmaceutical Preparations
  • Xenobiotics
  • Cytochrome P-450 Enzyme System